Matrix Metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 2, 2013, Pages 347-354

  Husmann, Knut ^a   Arlt, Matthias J E ^a   Muff, Roman ^a   Langsam, Bettina ^a   Bertz, Josefine ^a   Born, Walter ^a   Fuchs, Bruno ^a  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

In vivo; Intratibial mouse model; Metastasis; MMP 1; Osteosarcoma

Indexed keywords

COLLAGEN TYPE 1; INTERSTITIAL COLLAGENASE; MESSENGER RNA;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE CELL; CARCINOGENESIS; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; BASE SEQUENCE; BONE NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 1; MICE; MICE, SCID; OSTEOSARCOMA; REAL-TIME POLYMERASE CHAIN REACTION; TIBIA; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 84871742330     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.11.006     Document Type: Article

References (40)

1. Fuchs B., Pritchard D.J. Etiology of osteosarcoma. Clin. Orthop. Rel. Res. 2002, 397:40-52.
2. Khanna C., Hunter K. Modeling metastasis in vivo. Carcinogenesis 2005, 26:513-523.
3. Nguyen D.X., Bos P.D., Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9:274-284.
4. Skrzydlewska E., Sulkowska M., Koda M., Sulkowski S. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J. Gastroenterol. 2005, 11:1251-1266.
5. Brooks S.A., Lomax-Browne H.J., Carter T.M., Kinch C.E., Hall D.M. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010, 112:3-25.
6. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behaviour. Annu. Rev. Cell Dev. Biol. 2001, 17:463-516.
7. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
8. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006, 25:9-34.
9. Ala-aho R., Kähäri V.-M. Collagenases in cancer. Biochimie 2005, 87:273-286.
10. Brinckerhoff C.E., Rutter J.L., Benbow U. Interstitial collagenases as markers of tumor progression. Clin. Cancer Res. 2000, 6:4823-4830.
11. Murray G.I., Duncan M.E., O'Neil P., McKay J.A., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 1998, 185:256-261.
12. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 1996, 2:461-462.
13. Nikkola J., Vihinen P., Vlaykova T., Hahka-Kemppinen M., Kähäri V.-M., Pyrhönen S. High expression levels of collagenase-1 (MMP-1) and stromelysin-1 (MMP-3) correlate with shorter disease free survival in human metastatic melanoma. Int. J. Cancer 2002, 97:432-438.
14. Kawashima A., Okada Y., Nakanishi I., Ueda Y., Iwata K., Roessner A. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. Gen. Diagn. Pathol. 1997, 142:129-137.
15. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kekkonen S.M., Cordón-Cardo C., Guise T.A., Massagué J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
16. Cowan R.W., Mak I.W.Y., Colterjohn N., Singh G., Ghert M. Collagenase expression and activity in the stromal cells from giant cell tumour of bone. Bone 2009, 44:865-871.
17. Ferrari C., Benassi M.S., Ponticelli F., Gamberi G., Ragazzini P., Pazzaglia L., Balladelli A., Bertoni F., Picci P. Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years. Acta Orthop. Scand. 2004, 75:487-491.
18. Bjørnland K., Flatmark K., Pettersen S., Aaasen A.O., Fodstad O., Maelandsmo G.M. Matrix metalloproteinases participate in osteosarcoma invasion. J. Surg. Res. 2005, 127:151-156.
19. Uchibori M., Nishida Y., Nagasaka T., Yamada Y., Nakanishi K., Ishiguro N. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int. J. Oncol. 2006, 28:33-42.
20. Korpi J.T., Hagström J., Lehtonen N., Parkkinen J., Sorsa T., Salo T., Laitinen M. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg. Oncol. 2011, 20:e18-e22.
21. Walters D.K., Muff R., Langsam B., Gruber P., Born W., Fuchs B. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines. Invest. New Drugs 2007, 25:305-312.
22. Husmann K., Muff R., Bolander M.E., Sarkar G., Born W., Fuchs B. Cathepsins and osteosarcoma: expression analysis identifies cathepsin K as an indicator of metastasis. Mol. Carcinog. 2008, 47:66-73.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
24. Yuan J., Dutton C.M., Scully S.P. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J. Orthop. Res. 2005, 23:1467-1474.
25. Arlt M.J.E., Banke I.J., Walters D.K., Puskas G.J., Steinmann P., Muff R., Born W., Fuchs B. LacZ transgene expression in the subcutaneous Dunn/LM8 osteosarcoma mouse model allows for the identification of micrometastasis. J. Orthop. Res. 2011, 29:938-946.
26. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with Image J. Biophotonics Int. 2004, 11:36-42.
27. McAllister R.M., Gardner M.B., Greene A.E., Bradt C., Nichols W.W., Landing B.H. Cultivation in vitro of cells derived from a human osteosarcoma. Cancer 1971, 27:397-402.
28. Rhim J.S., Putman D.L., Arnstein P., Huebner R.J., McAllister R.M. Characterization of human cells transformed in vitro by N-methyl-N'-nitro-N-nitrosoguanidine. Int. J. Cancer 1977, 19:505-510.
29. Berlin O., Samid D., Donthineni-Rao R., Akeson W., Amiel D., Woods V.L. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res. 1993, 53:4890-4895.
30. Luu H.H., Kang Q., Park J.K., Si W., Luo Q., Jiang W., Yin H., Montag A.G., Simon M.A., Peabody T.D., Haydon R.C., Rinker-Schaeffer C.W., He T.C. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin. Exp. Metastasis 2005, 22:319-329.
31. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massagué J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
32. Eltarhouny S.A., Elsawy W.H., Radpour R., Hahn S., Holzgreve W., Zhong X.Y. Genes controlling spread of breast cancer to lung "gang of 4". Exp. Oncol. 2008, 30:91-95.
33. Kimura R., Ishikawa C., Rokkaku T., Janknecht R., Mori N. Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells. Biochim. Biophys. Acta 2011, 1813:1543-1553.
34. Jawad M.U., Garamszegi N., Garamszegi S.P., Correa-Medina M., Diez J.A., Wen R., Scully S.P. Matrix metalloproteinase 1: role in sarcoma biology. PLoS One 2010, 5:e14250.
35. Wyatt C.A., Geoghegan J.C., Brinckerhoff C.E. Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res. 2005, 65:11101-11108.
36. Eck S.M., Hoopes P.J., Petrella B.L., Coon C.I., Brinckerhoff C.E. Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Res. Treat. 2009, 116:79-90.
37. Gorlick R., Khanna C. Osteosarcoma. J. Bone Min. Res. 2010, 25:683-691.
38. Buijs J.T., van der Pluijm G. Osteotropic cancers: from primary tumor to bone. Cancer Lett. 2009, 273:177-193.
39. Nemeth J.A., Yousif R., Herzog M., Che M., Upadhyay J., Shekarriz B., Bhagat S., Mullins C., Fridman R., Cher M.L. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J. Natl. Cancer Inst. 2002, 94:17-25.
40. Giuliani N., Rizzoli V. Myeloma cells and bone marrow osteoblast interactions: role in the development of osteolytic lesions in multiple myeloma. Leuk. Lymphoma 2007, 48:2323-2329.